TP-0184 is an investigational inhibitor of activin A receptor type 1 (ACVR1) kinase, also known as ALK2. Inhibiting ACVR1 may have anti tumor effects in several types, decrease hepcidin expression, increase bioavailable iron, and restore levels of hemoglobin.
#cancer therapy #anti-tumor effects #hepcidin
#hemoglobin levels #ACVR
Keywords: 3D, Patient Education, Professional Education, Pharmacology, Oncology, Health & Wellness
© Jackie Heda